- The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome
-
Lener MR, Kashyap A, Kluźniak , Cybulski C, Soluch A, Pietrzak S, Huzarski T, Gronwald J, Lubiński
- KMID: 2378115
- Cancer Res Treat.
- 2017 Apr;49(2):430-436.
- doi: 10.4143/crt.2016.217
PURPOSE: Familial pancreatic cancer describes families with at least two first-degree relatives with pancreatic cancer that do not fulfil the criteria of other inherited tumor syndromes with increased risks of... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer
-
Lener MR, Scott RJ, Wiechowska-Kozłowska A, Serrano-Fernández P, Baszuk P, Jaworska-Bieniek K, Sukiennicki G, Marciniak , Muszyńska M, Kładny J, Gromowski , Kaczmarek , Jakubowska A, Lubiński
- KMID: 2344079
- Cancer Res Treat.
- 2016 Jul;48(3):1056-1064.
- doi: 10.4143/crt.2015.282
PURPOSE: Understanding of the etiology and pathogenesis of pancreatic cancer (PaCa) is still insufficient. This study evaluated the associations between concentrations of selenium (Se) and copper (Cu) in the serum... -
- CITED
-
- Close
- SHARE
-
- Close
- Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland
-
Dębniak T, Scott RJ, Lea RA, Górski B, Masojć B, Cybulski C, Kram A, Maleszka R, Gromowski , Paszkowska-Szczur K, Kashyap A, Lener MR, Malińska , Rogoża E, Murawa D, Rudnicka H, Deptuła J, Lubiński
- KMID: 2437624
- Cancer Res Treat.
- 2019 Jan;51(1):337-344.
- doi: 10.4143/crt.2018.157
PURPOSE: Germline mutations within melanoma susceptibility genes are present only in minority of melanoma patients and it is expected that additional genes will be discovered with next generation sequence technology... -
- CITED
-
- Close
- SHARE
-
- Close
